;PMID: 1314950
;source_file_2848.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..40] = [t:0..40]
;1)sentence:[e:46..179] = [t:46..179]
;2)section:[e:183..224] = [t:183..224]
;3)section:[e:228..330] = [t:228..330]
;4)sentence:[e:334..571] = [t:334..571]
;5)sentence:[e:572..716] = [t:572..716]
;6)sentence:[e:717..880] = [t:717..880]
;7)sentence:[e:881..1038] = [t:881..1038]
;8)sentence:[e:1039..1179] = [t:1039..1179]
;9)sentence:[e:1180..1288] = [t:1180..1288]
;10)section:[e:1292..1336] = [t:1292..1336]

;section 0 Span:0..40
;Mol Cell Biol.  1992 May;12(5):2193-202.
(SEC
  (FRAG (NNP:[0..3] Mol) (NNP:[4..8] Cell) (NNP:[9..13] Biol) (.:[13..14] .)
        (CD:[16..20] 1992) (NNP:[21..24] May) (CD:[24..28] ;12-LRB-)
        (CD:[28..29] 5) (-RRB-:[29..30] -RRB-) (::[30..31] :) (CD:[31..35] 2193)
        (CD:[35..39] -202) (.:[39..40] .)))

;sentence 1 Span:46..179
;Basic fibroblast growth factor enhances nerve growth factor receptor gene 
;promoter activity in human neuroblastoma cell line CHP100.
;[46..76]:gene-protein:"Basic fibroblast growth factor"
;[86..114]:gene-rna:"nerve growth factor receptor"
;[148..161]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ (JJ:[46..51] Basic) (NN:[52..62] fibroblast) (NN:[63..69] growth)
            (NN:[70..76] factor))
    (VP (VBZ:[77..85] enhances)
      (NP
        (NML (NN:[86..91] nerve) (NN:[92..98] growth) (NN:[99..105] factor)
             (NN:[106..114] receptor))
        (NML (NN:[115..119] gene) (NN:[121..129] promoter))
        (NN:[130..138] activity))
      (PP (IN:[139..141] in)
        (NP (JJ:[142..147] human) (NN:[148..161] neuroblastoma)
          (NML (NN:[162..166] cell) (NN:[167..171] line))
          (NN:[172..178] CHP100))))
    (.:[178..179] .)))

;section 2 Span:183..224
;Taiji M, Taiji K, Deyerle KL, Bothwell M.
(SEC
  (FRAG (NNP:[183..188] Taiji) (NNP:[189..191] M,) (NNP:[192..197] Taiji)
        (NNP:[198..200] K,) (NNP:[201..208] Deyerle) (NNP:[209..211] KL)
        (,:[211..212] ,) (NNP:[213..221] Bothwell) (NNP:[222..224] M.)))

;section 3 Span:228..330
;Department of Physiology and Biophysics, School of Medicine, University of 
;Washington, Seattle 98195.
(SEC
  (FRAG (NNP:[228..238] Department) (IN:[239..241] of)
        (NNP:[242..252] Physiology) (CC:[253..256] and)
        (NNP:[257..267] Biophysics) (,:[267..268] ,) (NNP:[269..275] School)
        (IN:[276..278] of) (NNP:[279..287] Medicine) (,:[287..288] ,)
        (NNP:[289..299] University) (IN:[300..302] of)
        (NNP:[304..314] Washington) (,:[314..315] ,) (NNP:[316..323] Seattle)
        (CD:[324..329] 98195) (.:[329..330] .)))

;sentence 4 Span:334..571
;The human neuroblastoma cell line CHP100 provides a useful model system in
;which  to study the molecular mechanisms of transcriptional regulation of the
; low-affinity nerve growth factor receptor (NGFR) gene during neuronal 
;development.
;[344..357]:malignancy-type:"neuroblastoma"
;[501..529]:gene-rna:"nerve growth factor receptor"
;[531..535]:gene-rna:"NGFR"
(SENT
  (S
    (NP-SBJ (DT:[334..337] The) (JJ:[338..343] human)
            (NN:[344..357] neuroblastoma)
      (NML (NN:[358..362] cell) (NN:[363..367] line))
      (NN:[368..374] CHP100))
    (VP (VBZ:[375..383] provides)
      (NP
        (NP (DT:[384..385] a) (JJ:[386..392] useful) (NN:[393..398] model)
            (NN:[399..405] system))
        (SBAR
          (WHPP-1 (IN:[406..408] in)
            (WHNP (WDT:[409..414] which)))
          (S
            (NP-SBJ (-NONE-:[414..414] *))
            (VP (TO:[416..418] to)
              (VP (VB:[419..424] study)
                (NP
                  (NP (DT:[425..428] the) (JJ:[429..438] molecular)
                      (NNS:[439..449] mechanisms))
                  (PP (IN:[450..452] of)
                    (NP
                      (NP (JJ:[453..468] transcriptional)
                          (NN:[469..479] regulation))
                      (PP (IN:[480..482] of)
                        (NP (DT:[483..486] the)
                          (NML (JJ:[488..491] low) (HYPH:[491..492] -)
                               (NN:[492..500] affinity))
                          (NML
                            (NML (NN:[501..506] nerve) (NN:[507..513] growth)
                                 (NN:[514..520] factor) (NN:[521..529] receptor))
                            (NML (-LRB-:[530..531] -LRB-) (NN:[531..535] NGFR)
                                 (-RRB-:[535..536] -RRB-)))
                          (NN:[537..541] gene)))
                      (PP-TMP (IN:[542..548] during)
                        (NP (JJ:[549..557] neuronal) (NN:[559..570] development))))))
                (PP-1 (-NONE-:[570..570] *T*))))))))
    (.:[570..571] .)))

;sentence 5 Span:572..716
;Basic fibroblast growth factor (bFGF) induced morphological changes  in
;CHP100 cells, including flattening of cell bodies and neurite outgrowth.
;[572..602]:gene-protein:"Basic fibroblast growth factor"
;[604..608]:gene-protein:"bFGF"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[572..577] Basic) (NN:[578..588] fibroblast)
          (NN:[589..595] growth) (NN:[596..602] factor))
      (NP (-LRB-:[603..604] -LRB-) (NN:[604..608] bFGF) (-RRB-:[608..609] -RRB-)))
    (VP (VBD:[610..617] induced)
      (NP (JJ:[618..631] morphological) (NNS:[632..639] changes))
      (PP-LOC (IN:[641..643] in)
        (NP (NN:[644..650] CHP100) (NNS:[651..656] cells)))
      (,:[656..657] ,)
      (PP (VBG:[658..667] including)
        (NP
          (NP
            (NP (NN:[668..678] flattening))
            (PP (IN:[679..681] of)
              (NP (NN:[682..686] cell) (NNS:[687..693] bodies))))
          (CC:[694..697] and)
          (NP (NN:[698..705] neurite) (NN:[706..715] outgrowth)))))
    (.:[715..716] .)))

;sentence 6 Span:717..880
;bFGF  also increased p75NGFR immunoreactivity, as assessed by
;immunocytochemistry, and  increased p75NGFR mRNA levels, as assessed by
;Northern (RNA) blot analysis.
;[717..721]:gene-protein:"bFGF"
;[738..745]:gene-protein:"p75NGFR"
;[815..822]:gene-rna:"p75NGFR"
(SENT
  (S
    (NP-SBJ (NN:[717..721] bFGF))
    (VP
      (VP
        (ADVP (RB:[723..727] also))
        (VBD:[728..737] increased)
        (NP (NN:[738..745] p75NGFR) (NN:[746..762] immunoreactivity))
        (,:[762..763] ,)
        (SBAR-ADV (IN:[764..766] as)
          (S
            (NP-SBJ (-NONE-:[766..766] *))
            (VP (VBN:[767..775] assessed)
              (NP (-NONE-:[775..775] *))
              (PP-MNR (IN:[776..778] by)
                (NP (NN:[779..798] immunocytochemistry)))))))
      (,:[798..799] ,) (CC:[800..803] and)
      (VP (VBD:[805..814] increased)
        (NP (NN:[815..822] p75NGFR) (NN:[823..827] mRNA) (NNS:[828..834] levels))
        (,:[834..835] ,)
        (SBAR-ADV (IN:[836..838] as)
          (S
            (NP-SBJ-1 (-NONE-:[838..838] *))
            (VP (VBN:[839..847] assessed)
              (NP-1 (-NONE-:[847..847] *))
              (PP (IN:[848..850] by)
                (NP-LGS (JJ:[851..859] Northern)
                  (NML (-LRB-:[860..861] -LRB-) (NN:[861..864] RNA)
                       (-RRB-:[864..865] -RRB-))
                  (NN:[866..870] blot) (NN:[871..879] analysis))))))))
    (.:[879..880] .)))

;sentence 7 Span:881..1038
;A  chimeric gene consisting of 6.7 kb of the 5'-flanking region of the human
;NGFR  gene linked to the chloramphenicol acetyltransferase gene was
;constructed.
;[958..962]:gene-rna:"NGFR"
;[983..1016]:gene-rna:"chloramphenicol acetyltransferase"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[881..882] A) (JJ:[884..892] chimeric) (NN:[893..897] gene))
      (VP (VBG:[898..908] consisting)
        (PP-CLR (IN:[909..911] of)
          (NP
            (NP (CD:[912..915] 6.7) (NN:[916..918] kb))
            (PP (IN:[919..921] of)
              (NP
                (NP
                  (NP (DT:[922..925] the)
                    (ADJP
                      (NML (CD:[926..927] 5) (SYM:[927..928] '))
                      (HYPH:[928..929] -) (NN:[929..937] flanking))
                    (NN:[938..944] region))
                  (PP (IN:[945..947] of)
                    (NP (DT:[948..951] the) (JJ:[952..957] human)
                        (NN:[958..962] NGFR) (NN:[964..968] gene))))
                (VP (VBN:[969..975] linked)
                  (PP (TO:[976..978] to)
                    (NP (DT:[979..982] the)
                       (NN:[983..998] chloramphenicol)
                       (NN:[999..1016] acetyltransferase)
                      (NN:[1017..1021] gene))))))))))
    (VP (VBD:[1022..1025] was)
      (VP (VBN:[1026..1037] constructed)
        (NP-1 (-NONE-:[1037..1037] *))))
    (.:[1037..1038] .)))

;sentence 8 Span:1039..1179
;In  stable transformants of CHP100 cells, 10 ng of bFGF per ml induced an
;eightfold  increase in chloramphenicol acetyltransferase activity.
;[1090..1094]:gene-protein:"bFGF"
;[1136..1169]:gene-protein:"chloramphenicol acetyltransferase"
(SENT
  (S
    (PP-LOC (IN:[1039..1041] In)
      (NP
        (NP (JJ:[1043..1049] stable) (NNS:[1050..1063] transformants))
        (PP (IN:[1064..1066] of)
          (NP (NN:[1067..1073] CHP100) (NNS:[1074..1079] cells)))))
    (,:[1079..1080] ,)
    (NP-SBJ
      (NP (CD:[1081..1083] 10) (NN:[1084..1086] ng))
      (PP (IN:[1087..1089] of)
        (NP (NN:[1090..1094] bFGF)))
      (PP (IN:[1095..1098] per)
        (NP (NN:[1099..1101] ml))))
    (VP (VBD:[1102..1109] induced)
      (NP
        (NP (DT:[1110..1112] an) (JJ:[1113..1122] eightfold)
            (NN:[1124..1132] increase))
        (PP (IN:[1133..1135] in)
          (NP
             (NN:[1136..1151] chloramphenicol)
             (NN:[1152..1169] acetyltransferase)
            (NN:[1170..1178] activity)))))
    (.:[1178..1179] .)))

;sentence 9 Span:1180..1288
;These results indicate  that upstream elements of the NGFR gene mediate
;transcriptional regulation by  bFGF.
;[1234..1238]:gene-rna:"NGFR"
;[1283..1287]:gene-protein:"bFGF"
(SENT
  (S
    (NP-SBJ (DT:[1180..1185] These) (NNS:[1186..1193] results))
    (VP (VBP:[1194..1202] indicate)
      (SBAR (IN:[1204..1208] that)
        (S
          (NP-SBJ
            (NP (JJ:[1209..1217] upstream) (NNS:[1218..1226] elements))
            (PP (IN:[1227..1229] of)
              (NP (DT:[1230..1233] the) (NN:[1234..1238] NGFR)
                  (NN:[1239..1243] gene))))
          (VP (VBP:[1244..1251] mediate)
            (NP
              (NP (JJ:[1252..1267] transcriptional) (NN:[1268..1278] regulation))
              (PP (IN:[1279..1281] by)
                (NP (NN:[1283..1287] bFGF))))))))
    (.:[1287..1288] .)))

;section 10 Span:1292..1336
;PMID: 1314950 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1292..1296] PMID) (::[1296..1297] :) (CD:[1298..1305] 1314950)
        (NN:[1306..1307] -LSB-) (NNP:[1307..1313] PubMed) (::[1314..1315] -)
        (NN:[1316..1323] indexed) (IN:[1324..1327] for)
        (NNP:[1328..1336] MEDLINE-RSB-)))
